Oxygen Consumption After Acute Whole Body Vibration Session

Acute Effects on Oxygen Consumption and Blood Flow After a Single Session of Whole Body Vibration

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02774577

Enrollment

Registered

2016-05-17

Start date

2016-06-01

Completion date

2017-06-01

Last updated

2017-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Oxygen Consumption

Keywords

Oxygen Consumption, Aged, Whole Body Vibration

Brief summary

Noninvasive assessment of VO2 during a single session of whole body vibration and changes in blood flow caused by the acute activity.

Detailed description

A single whole body vibration session into two groups, a young adults groups and elderly group, booth healthy, will be held with concomitant collection of VO2 consumed during the session, by MetaMax cortex. Immediately after the session, it will be checked peripheral blood flow through US surface in color Doppler mode.

Interventions

OTHERwhole body vibration training in vibrating platform in young

OTHERwhole body vibration training in vibrating platform in elderly

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Masking description

similar procedures for variables, collected into similar device and positioning, using a sham device, patented, witch reproduce infra-physiologic vibrations and sound like an actual vibrating platform

Intervention model description

acute wbv session, measuring ergospirometric variables during protocol and blood pressure, borg exertion, borg dyspnoea, blood lactate, heart rate and SpO2 before and after protocol.

Eligibility

Sex/Gender

ALL

Age

20 Years to 74 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy young adults (between 20 to 30 years) and healthy elderly (between 60 to 74 years), sedentary according International Physical Activity Questionnaire.

Exclusion criteria

* presence of thrombosis, labyrinthitis, osteoporosis and individuals who have difficulty adapting to the assessment or training protocol.

Design outcomes

Primary

Measure	Time frame	Description
VO2 through the gas exchange measured by Cortex Metamax	up to 06 months	an atoxic mask measure oxygen consumption and carbon dioxide production in ml/kg/min-1, breathe by breathe
peripheral blood Lactate	up to 06 months	a noninvasive evaluate using an Lactimeter

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026